QuickView for ErbB-2 class receptor binding (biogroup)

1. Whole kidneys from aging female and male rats
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
4. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
5. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens

There were no matches for ErbB-2 class receptor binding

1. Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer
2. Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer
3. Tarlox and Sotorasib in Patients With KRAS G12C Mutations
4. Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previous…